Bortezomib Active Not Recruiting Phase 1 Trials for Myelodysplastic Syndrome / Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02312102Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation